Immuno-Biological Laboratories Co.,Ltd. (4570.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

46.9x

EV/EBITDA

24.5x

Market Cap

JPY 9.75B

MomentumView details →

1D Return

+1.65%

YTD Return

−43.96%

RSI (14)

54.3

ValuationView details →

P/E (Fwd)

46.9x

EV/EBITDA

24.5x

Market Cap

JPY 9.75B

RSI (14)

54.3

MomentumView details →

1D Return

+1.65%

YTD Return

−43.96%

ProfitabilityView details →

Gross Margin

70.42%

Net Margin

32.77%

EBITDA Margin

29.83%

ROE (TTM)

17.85%

ROA (TTM)

15.27%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+3.61%

EPS YoY

+32.13%

FCF YoY

—

Revenue CAGR 3Y

+8.14%

EPS CAGR 3Y

+32.74%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

5.68x

Quick Ratio

5.43x

Div Yield

0.57%

Div Rate

JPY 6.00

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.00B

Net Income (TTM)

329.00M

Op. CF (TTM)

—

Next earningsOct 30, 2026 →

Latest newsMore news →

Immuno-Biological Laboratories completed the animal testing part of the GLP-compliant repeated-dose toxicity study for anti-HIV antibodies related to jointly held patents.8d ago

Similar companies

KAINOS Laboratories,Inc.4556.T K Pharma,Inc.4896.T MORISHITA JINTAN CO.,LTD.4524.T WAKAMOTO PHARMACEUTICAL CO.,LTD.4512.T MediciNova,Inc.4875.T Kidswell Bio Corporation4584.T Find similar companies →

Latest newsMore news →

Immuno-Biological Laboratories completed the animal testing part of the GLP-compliant repeated-dose toxicity study for anti-HIV antibodies related to jointly held patents.8d ago